1 / 10

Parkinson's Disease Market

Parkinsonu2019s Disease is a progressive condition involving dysfunction or loss of dopamine producing neurons in the brain. Dopamine is a neurotransmitter that aids the bodyu2019s ability to carry out coordinated movement.<br>

DelveInsight
Download Presentation

Parkinson's Disease Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parkinson’s Disease Market Insights, Epidemiology and Market Forecast- 2028

  2. Parkinson’s Disease • The hallmarks of the disease are degeneration of dopaminergic neurons in the substantianigra pars compacta of the midbrain and the presence of Lewybodies. Parkinson’s disease classification includes Juvenile Parkinson’s Disease, Young-onset Parkinson’s disease, and Idiopathic Parkinson’s Disease. The female-to-male ratio for prevalent cases is different. • Parkinson’s Disease is a progressive condition involving dysfunction or loss of dopamine producing neurons in the brain. Dopamine is a neurotransmitter that aids the body’s ability to carry out coordinated movement. The decreased levels of dopamine that underlie the disease are characterized by difficulty with both voluntary and involuntary movements. It also involves non-motor symptoms such as depression, and orthostatic hypotension. • DelveInsight © 2019 | All rights reserved

  3. Parkinson’s Disease Epidemiology • Parkinson’s Disease total prevalent population in the 7MM* countries was observed to be 1,608,367 in 2017 that is expected to reach up to 1,706,922 by 2028, growing at a CAGR of 0.54% for the study period [2017–2028]. Based on gender of the prevalent population, it was observed that more than half of Parkinson’s diseasediagnosed prevalent cases were occupied by males, with 729,965 in the 7MM countries in 2017, while females accounted for nearly 46.86% cases. Parkinson’s diseasediagnosed prevalent population was assessed to be highest for the United States, accounting for 44.29% of the total patient pool among the 7MM countries, which is equivalent to 608,357 cases in 2017. Among the EU-5 countries, Germany witnessed the highest diagnosed prevalent population accounting for more than 25.45% of the total diagnosed cases, followed by Italy and Francewhereas Spain witnessed the lowest number of diagnosed cases in 2017. Parkinson’s Disease total diagnosed prevalent population ranged from 1,373,639 in 2017 to 1,536,230 in 2028, growing at a CAGR of 1.02% for the study period [2017–2028]. *7MM includes:- United States; EU-5 (Germany, France, Spain, Italy, United Kingdom); Japan. • DelveInsight © 2019 | All rights reserved

  4. Parkinson’s Disease Market Market Size in 7MM United States Market Size Among the 7MM, theUnited States accounted for the majority of the market size with USD 941.13 million in 2017. Parkinson’s disease market size in the 7MM is expected to reach USD 4356.14 million by2028 from USD 1837.90 million in 2017. Germany has the second highest market size after the United States in 2017, which is accounted for USD 150.33 million. Gene therapy, by MeiraGTxHoldings, AAV-GAD is expected to grab the highest market size with USD 1,609.40 million by 2028 Germany Market Size Gene therapy • DelveInsight © 2019 | All rights reserved

  5. Parkinson’s Disease Emerging Drugs and Companies Drug - Istradefylline Company - Kyowa Kirin Drug - LY03003 Company- Luye Pharma Drug - Opicapone Company- Neurocrine Biosciences Drug - P2B001 Company - Pharma Two B Ltd • DelveInsight © 2019 | All rights reserved

  6. Complete Information For complete information on Parkinson’s Disease Market Insight, Epidemiology and Market Forecast - 2028 please click the link below Click here OR Write Us At  info@delveinsight.com • DelveInsight © 2019 | All rights reserved

  7. About DelveInsight VISION ABOUT To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. MISSION MISSION To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. • DelveInsight © 2019 | All rights reserved

  8. Services Offerings by DelveInsight OPPORTUNITY ASSESSMENT FORECASTING DELVEINSIGHT REPORT STORE PIPELINE PHARMDELVE CONSULTING COMPETITIVE ANALYSIS MARKET INTELLIGENCE • DelveInsight © 2019 | All rights reserved

  9. Contact Us info@delveinsight.com blog/delveInsight/ twitter/delveInsight +91-11-4568 9769 LinkedIn/delveInsight www.delveinsight.com • DelveInsight © 2019 | All rights reserved

  10. THANK YOU

More Related